Results
Balaxi Pharmaceuticals Q2 PAT Surges 450% YoY
• Investor presentation details Q2 FY27 consolidated PAT surge of 450% YoY to ₹115.02 lakhs on revenue growth of 39.44%.
• Highlights operational commencement of Jadcherla formulation facility and add